Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F X Wese

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Acta Urologica Belgica|March 1, 1996
[Treatment of hypospadias: 15-year experience]J Mostin, A Feyarts, F Veyckemans, et al.
Acta Urologica Belgica|January 1, 1983
[Primary transitional epithelioma of the prostate. Apropos of 2 cases]P Ferrant, M A Degels, F X Wese, et al.
Acta Urologica Belgica|September 1, 1994
[Cholesteatoma of the upper urinary tract: endoscopic treatment]P François, J M Parmentier, A N Dardenne, et al.
Journal of Endourology|April 1, 1996
Vessels around the ureteropelvic junction: significance and imaging by conventional radiologyP J Van Cangh, S Nesa, M Galeon, et al.
European Urology|January 1, 1992
Muscle regeneration after endoureteropyelotomy?P J Van Cangh, J P Cosyns, G Lagneaux, et al.
Acta Urologica Belgica|June 1, 1994
[Application of color Doppler in genitourinary pathology in adults]A N Dardenne, T Puttemans, F X Wese, et al.
The Prostate. Supplement|January 1, 1996
Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancerP J Van Cangh, P De Nayer, P Sauvage, et al.
Urology|December 1, 1996
Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSAP J Van Cangh, P De Nayer, L De Vischer, et al.
Annales D'Urologie|January 1, 1989
[Ureteral lithiasis. Development of the therapeutic strategy and the place of endoscopic treatment]J L Jorion, F Lorge, P N Hennebert, et al.
Acta Urologica Belgica|March 1, 1995
[Percutaneous treatment of tumors of the upper urinary tract]S Nesa, J P Cosyns, A Saleh, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Acta Urologica Belgica|March 1, 1996
[Treatment of hypospadias: 15-year experience]J Mostin, A Feyarts, F Veyckemans, et al.
Acta Urologica Belgica|January 1, 1983
[Primary transitional epithelioma of the prostate. Apropos of 2 cases]P Ferrant, M A Degels, F X Wese, et al.
Acta Urologica Belgica|September 1, 1994
[Cholesteatoma of the upper urinary tract: endoscopic treatment]P François, J M Parmentier, A N Dardenne, et al.
Journal of Endourology|April 1, 1996
Vessels around the ureteropelvic junction: significance and imaging by conventional radiologyP J Van Cangh, S Nesa, M Galeon, et al.
European Urology|January 1, 1992
Muscle regeneration after endoureteropyelotomy?P J Van Cangh, J P Cosyns, G Lagneaux, et al.
Acta Urologica Belgica|June 1, 1994
[Application of color Doppler in genitourinary pathology in adults]A N Dardenne, T Puttemans, F X Wese, et al.
The Prostate. Supplement|January 1, 1996
Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancerP J Van Cangh, P De Nayer, P Sauvage, et al.
Urology|December 1, 1996
Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSAP J Van Cangh, P De Nayer, L De Vischer, et al.
Annales D'Urologie|January 1, 1989
[Ureteral lithiasis. Development of the therapeutic strategy and the place of endoscopic treatment]J L Jorion, F Lorge, P N Hennebert, et al.
Acta Urologica Belgica|March 1, 1995
[Percutaneous treatment of tumors of the upper urinary tract]S Nesa, J P Cosyns, A Saleh, et al.
Pageof 11